Candel Therapeutics Stock

candeltx.comHealthcare / BioTech & PharmaFunding to Date: $67.6MM

Developer of cancer immunotherapies designed to improve the lives of cancer patients and their families. The company's immunotherapies focus on preventing the recurrence and progression of cancer with low toxicity level which is well suited for the treatment of less aggressive or slower growing cancers such as newly diagnosed prostate cancer, enabling physicians to ensure improved outcomes for their patients and help them recover faster.

Register To Buy and Sell Shares

For more details on financing and valuation for Candel Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Candel Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Candel Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Stephen Rocamboli JD
Chief Business Officer
Laura Aguilar Ph.D
Chief Medical Officer
Estuardo Aguilar-Cordova Ph.D
Chief Executive Officer, Chairman and Co-Founder
Daniel Giroux
Vice President, Manufacturing
Brian Guzik Ph.D
Senior Director, Business Development

Board Members

Christopher Martell
Fred Mermelstein Ph.D
Michael Rubin MD
Northpond Ventures
Udi Meirav Ph.D
Edward Benz Jr.
Estuardo Aguilar-Cordova Ph.D
Glenn Mattes
Paul Manning
Alan Smith
Gregory Gailius
Mitchell Finer Ph.D
Sean Stalfort

Frequently Asked Questions About Candel Therapeutics’ Stock

Can you buy Candel Therapeutics’ stock?
Candel Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Candel Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Candel Therapeutics’ stock?
Yes, you can sell stock of a private company like Candel Therapeutics. Forge can help you sell your Candel Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Candel Therapeutics’ stock price?
Candel Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Candel Therapeutics’ private market stock price with Forge Data.
What is Candel Therapeutics’ stock ticker symbol?
Candel Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Candel Therapeutics Completes $22.5M Series C Funding | FinSMEs
Advantagene, d.b.a. Candel Therapeutics, a company developing proprietary immuno-oncology platforms, closed a $22.5m Series C financing
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.